Incidence and prevalence of NMOSD in Australia and New Zealand
<h4>Objectives</h4> <p>We have undertaken a clinic-based survey of neuromyelitis optica spectrum disorders (NMOSDs) in Australia and New Zealand to establish incidence and prevalence across the region and in populations of differing ancestry.</p> <h4>Background</h4&...
Main Authors: | Bukhari, W, Prain, KM, Waters, P, Woodhall, M, O'Gorman, CM, Clarke, L, Silvestrini, RA, Bundell, CS, Abernethy, D, Bhuta, S, Blum, S, Boggild, M, Boundy, K, Brew, BJ, Brown, M, Brownlee, WJ, Butzkueven, H, Carroll, WM, Chen, C, Coulthard, A, Dale, RC, Das, C, Dear, K, Fabis-Pedrini, MJ, Fulcher, D, Gillis, D, Hawke, S, Heard, R, Henderson, APD, Heshmat, S, Hodgkinson, S, Jimenez-Sanchez, S, Killpatrick, T, King, J, Kneebone, C, Kornberg, AJ, Lechner-Scott, J, Lin, M-W, Lynch, C, Macdonell, R, Mason, DF, McCombe, PA, Pender, MP, Pereira, JA, Pollard, JD, Reddel, SW, Shaw, C, Spies, J, Stankovich, J, Sutton, I, Vucic, S, Walsh, M, Wong, RC, Yiu, EM, Barnett, MH, Kermode, AG, Marriott, MP, Parratt, JDE, Slee, M, Taylor, BV, Willoughby, E, Wilson, RJ, Vincent, A, Broadley, SA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2017
|
Similar Items
-
The clinical profile of NMOSD in Australia and New Zealand
by: Bukhari, W, et al.
Published: (2020) -
AQP4 antibody assay sensitivity comparison in the era of the 2015 diagnostic criteria for NMOSD
by: Prain, K, et al.
Published: (2019) -
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation
by: Elham Khalilidehkordi, et al.
Published: (2020-06-01) -
AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
by: Kerri Prain, et al.
Published: (2019-10-01) -
Characterization of NMO and NMOSD Patients with a Late Onset
by: Collongues, N, et al.
Published: (2013)